Onset and Duration of Forearm Nerve Blockade

NCT03649763 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2019-02-26

No results posted yet for this study

Summary

This pilot study will evaluate the latency of onset and duration of sensory-motor block in patients undergoing hand surgery. Patients will be randomized to receive nerve blocks of the distal forearm or of the distal and proximal forearm. Local anesthetic will be injected to anesthetise the median and ulnar nerves in the distal forearm (1-injection site group) or the median and ulnar nerves in the distal and proximal forearm (2-sequential injection sites group) to accomplish anesthesia for surgery on the hand.

Conditions

  • Carpal Tunnel Syndrome

Interventions

DRUG

Lidocaine

lidocaine 1%, distal ( ulnar and medial nerve): 6ml/nerve , 12m total

DRUG

Bupivacaine

Bupivacaine 0.5%,distal ( ulnar and medial nerve): 6ml/nerve , 12m total

DRUG

Lidocaine

lidocaine 1%, distal and proximal ( ulnar and medial nerve): 3ml/nerve , 12m total

Sponsors & Collaborators

  • New York School of Regional Anesthesia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-07
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03649763 on ClinicalTrials.gov